149 related articles for article (PubMed ID: 21734448)
21. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
22. 14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion
Jung JY; Koh SA; Lee KH; Kim JR
Anticancer Res; 2022 Jan; 42(1):519-530. PubMed ID: 34969762
[TBL] [Abstract][Full Text] [Related]
23. Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in Gastric Cancer Cells.
Jung JY; Koh SA; Lee KH
Anticancer Res; 2024 May; 44(5):1973-1981. PubMed ID: 38677740
[TBL] [Abstract][Full Text] [Related]
24. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer.
Lee KH; Choi EY; Kim MK; Kim KO; Jang BI; Kim SW; Kim SW; Song SK; Kim JR
Mol Cell Biochem; 2010 Oct; 343(1-2):163-71. PubMed ID: 20559690
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
Lee KH; Kim JR
Exp Mol Med; 2009 Mar; 41(3):180-8. PubMed ID: 19293637
[TBL] [Abstract][Full Text] [Related]
27. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
28. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells.
Nishimura K; Matsumiya K; Miura H; Tsujimura A; Nonomura N; Matsumoto K; Nakamura T; Okuyama A
Int J Androl; 2003 Jun; 26(3):175-9. PubMed ID: 12755996
[TBL] [Abstract][Full Text] [Related]
29. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
30. Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
Xie Q; Gao CF; Shinomiya N; Sausville E; Hay R; Gustafson M; Shen Y; Wenkert D; Vande Woude GF
Oncogene; 2005 May; 24(23):3697-707. PubMed ID: 15782129
[TBL] [Abstract][Full Text] [Related]
31. Effect of hepatocyte growth factor (HGF) on the level of Survivin & XIAP expression in several human cancer cell lines, after treating with DNA damaging agent.
Keyhanian K; Edalat R; Oghalaei A; Askary N; Golshani A; Salehi M; Sarrami-Forooshani R; Shokrgozar MA
Mol Cell Biochem; 2007 Oct; 304(1-2):199-205. PubMed ID: 17534699
[TBL] [Abstract][Full Text] [Related]
32. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
33. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
34. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
[TBL] [Abstract][Full Text] [Related]
35. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC
Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807
[TBL] [Abstract][Full Text] [Related]
36. HGF-mediated Up-regulation of PHLDA2 Is Associated With Apoptosis in Gastric Cancer.
Koh SA; Lee KH
Anticancer Res; 2021 Sep; 41(9):4377-4385. PubMed ID: 34475057
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
38. [Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].
Li Y; Fan LQ; Sun Y; Zhao Q; Tan BB; Liu Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):265-9. PubMed ID: 21575496
[TBL] [Abstract][Full Text] [Related]
39. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
40. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
Cao W; Fan R; Wang L; Cheng S; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):963-71. PubMed ID: 23264087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
